A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
- PMID: 32241301
- PMCID: PMC7117947
- DOI: 10.1186/s13054-020-2836-4
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Comment in
-
Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure.Crit Care. 2020 May 15;24(1):226. doi: 10.1186/s13054-020-02943-1. Crit Care. 2020. PMID: 32414417 Free PMC article. No abstract available.
-
First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19.Crit Care. 2020 Jun 18;24(1):363. doi: 10.1186/s13054-020-03070-7. Crit Care. 2020. PMID: 32552832 Free PMC article. No abstract available.
References
-
- Hawkins D, Knowles H, Brice-Saddler M et al. US coronavirus death toll reaches 17; at least half of US states confirm cases. Washington Post 2020. https://www.washingtonpost.com/world/2020/03/06/coronavirus-live-updates. Accessed 7 Mar 2020.
-
- Blooberg. China finds promising coronavirus treatment in blood plasma. Fortune. February 14, 2020. https://fortune.com/2020/02/14/china-coronavirus-treatment-blood-plasma-.... Accessed 7 Mar 2020.
-
- Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16–24 February 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mis....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical